Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14,751 | N/A | N/A | N/A |
| Depreciation Amortization | 3,055 | N/A | N/A | N/A |
| Income taxes - deferred | 156 | N/A | N/A | N/A |
| Accounts receivable | -3,373 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -49 | N/A | N/A | N/A |
| Other Working Capital | -1,377 | N/A | N/A | N/A |
| Other Operating Activity | 2,563 | 0 | 0 | 0 |
| Operating Cash Flow | $-13,776 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -10,000 | N/A | N/A | N/A |
| PPE Investments | -2,869 | N/A | N/A | N/A |
| Other Investing Activity | -23 | 0 | 0 | 0 |
| Investing Cash Flow | $-12,892 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 30,000 | N/A | N/A | N/A |
| Debt Repayment | -25,041 | N/A | N/A | N/A |
| Common Stock Issued | 4 | N/A | N/A | N/A |
| Other Financing Activity | 23,598 | 0 | 0 | 0 |
| Financing Cash Flow | $28,561 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,244 | N/A | N/A | N/A |
| End Cash Position | 12,137 | N/A | N/A | N/A |
| Net Cash Flow | $1,893 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -13,776 | N/A | N/A | N/A |
| Capital Expenditure | -2,869 | N/A | N/A | N/A |
| Free Cash Flow | -16,645 | 0 | 0 | 0 |